Virtual Meeting to be held on February 27 hosted by BTIG.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving ...

As previously reported, BTIG upgraded Snowflake (SNOW) to Buy from Neutral with a $220 price target After two-plus years of Snowflake dealing ...

Wall Street is gearing up for another wave of blank check companies from seasoned and first-time sponsors, showing the ...

Medical Technology Analyst Zimmerman holds a virtual meeting with EVP & CFO Saccaro and Chief Investor Relations Officer Borders on February 21 ...

Investing.com -- BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...

BTIG lowered the firm’s price target on Evolent Health (EVH) to $20 from $29 but keeps a Buy rating on the shares. The firm notes it was disappointed by the company’s comments around higher ...

As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...

But before that let's have a chartist view from BTIG's technical guru Jonathan Krinsky. He notes that the S&P 500's rally off this week's lows is quite impressive and sets up the stock barometer ...